IMMUTEP LIMITED — Capital/Financing Update 2008

Mar 3, 2008

==> picture [187 x 51] intentionally omitted <==

4[th] March 2008

Company Announcements Office Australian Securities Exchange Level 45, Rialto South Tower 525 Collins Street Melbourne VIC 3000

Dear Sir/Madam,

Rights Issue Closed

The Directors are pleased to announce that the Company’s 1:3 Non-Renounceable Rights Issue of options is closed with 40% of the entitlement taken up.

The Company has received total acceptances for 39,693,058 options issued under the Rights Issue at an issue price of $0.002 cents per share raising a total of $79,386.12 (before costs).

Notice of the shortfall of 60,000,247 options has been given to the underwriter, RM Capital Pty Ltd.

Yours faithfully

==> picture [168 x 71] intentionally omitted <==

Robert Kleine Company Secretary

Prima BioMed Limited , Suite 1705, 109 Pitt Street, Sydney, NSW 2000 AUSTRALIA Ph: +61 (0)2 9232 4420 Fax: +61 (0)2 9232 4450 www.primabiomed.com.au ABN: 90 009 237 889